RNA logo

RNA
Avidity Biosciences Inc

1,707
Mkt Cap
$10.67B
Volume
2.39M
52W High
$71.09
52W Low
$21.51
PE Ratio
-16.98
RNA Fundamentals
Price
$70.80
Prev Close
$70.84
Open
$70.80
50D MA
$52.87
Beta
1.29
Avg. Volume
7.55M
EPS (Annual)
-$2.89
P/B
5.51
Rev/Employee
$27,869.56
Loading...
Loading...
News
all
press releases
Avidity Biosciences (NASDAQ:RNA) Reaches New 1-Year High - Should You Buy?
Avidity Biosciences (NASDAQ:RNA) Sets New 12-Month High - What's Next...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Chardan Capital Reiterates "Neutral" Rating for Avidity Biosciences (NASDAQ:RNA)
Chardan Capital reissued a "neutral" rating and issued a $72.00 price objective on shares of Avidity Biosciences in a report on Tuesday...
MarketBeat·3d ago
News Placeholder
Avidity Biosciences (NASDAQ:RNA) Issues Quarterly Earnings Results, Misses Estimates By $0.22 EPS
Avidity Biosciences (NASDAQ:RNA - Get Free Report) issued its quarterly earnings data on Monday. The biotechnology company reported ($1.27) earnings per share for the quarter, missing the consensus...
MarketBeat·3d ago
News Placeholder
Avidity Biosciences, Inc. (RNA) Reports Q3 Loss, Beats Revenue Estimates
Avidity Biosciences (RNA) delivered earnings and revenue surprises of -20.95% and +399.00%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4d ago
News Placeholder
Avidity Biosciences Reports Third Quarter 2025 Financial Results and Recent Highlights
Avidity Biosciences Reports Third Quarter 2025 Financial Results and Recent Highlights Avidity Biosciences Reports Third Quarter 2025 Financial Results and Recent Highlights PR Newswire SAN DIEGO...
PR Newswire·4d ago
News Placeholder
Halper Sadeh LLC Encourages WTRG, PLYM, RNA Shareholders to Contact the Firm to Discuss Their Rights
Halper Sadeh LLC Encourages WTRG, PLYM, RNA Shareholders to Contact the Firm to Discuss Their Rights Halper Sadeh LLC Encourages WTRG, PLYM, RNA Shareholders to Contact the Firm to Discuss Their...
PR Newswire·7d ago
News Placeholder
Ovid Therapeutics (OVID) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
Ovid Therapeutics (OVID) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·11d ago
News Placeholder
Halper Sadeh LLC Encourages RNA, JAMF, AWK Shareholders to Contact the Firm to Discuss Their Rights
Halper Sadeh LLC Encourages RNA, JAMF, AWK Shareholders to Contact the Firm to Discuss Their Rights Halper Sadeh LLC Encourages RNA, JAMF, AWK Shareholders to Contact the Firm to Discuss Their Rights...
PR Newswire·16d ago
News Placeholder
Analysts Estimate Avidity Biosciences, Inc. (RNA) to Report a Decline in Earnings: What to Look Out for
Avidity Biosciences (RNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·16d ago
News Placeholder
Shareholder Alert: The Ademi Firm investigates whether Avidity Biosciences Inc. is obtaining a Fair Price for its Public Shareholders
Shareholder Alert: The Ademi Firm investigates whether Avidity Biosciences Inc. is obtaining a Fair Price for its Public Shareholders Shareholder Alert: The Ademi Firm investigates whether Avidity...
PR Newswire·18d ago

Latest RNA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.